We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

EKF Diagnostics

Manufactures analysers for the measurement of glucose, lactate, hemoglobin, hematocrit and HbA1c for GP surgeries, ph... read more Featured Products: More products

Download Mobile App




New Tools for Monitoring Blood Status and Infection

By LabMedica International staff writers
Posted on 03 Nov 2014
Two new diagnostic tools relating to blood status and infection will be introduced at Medica, the annual showcase for biomedical products.

EKF Diagnostics (Cardiff, United Kingdom) announced that it will be highlighting its DiaSpect hemoglobin analyzer and Liquicolor Procalcitonin immunoturbidimetric assay for sepsis at this year's Medica (Düsseldorf, Germany, November 12–15, 2014). More...


DiaSpect is a palm-sized point of care analyzer that is fast, easy to use, and reliable in all climate conditions. The instrument utilizes reagent-free microcuvettes, which are unaffected by humidity, unlike reagent-based systems. These plexiglass microcuvettes also have a long shelf-life of 2.5 years with no need for refrigeration, as they can be stored from zero to 50 degrees Celsius. DiaSpect weighs only 185 grams and has an extremely long battery life of 40 days of continuous use, or 10,000 tests, due to its integrated rechargeable lithium-ion battery. DiaSpect is factory calibrated and requires no recalibration or maintenance, as it performs an automatic self-check between every measurement. Hemoglobin results, which are delivered in just one second, can be downloaded to a PC via USB or Bluetooth.

EKF’s novel test for early sepsis detection, the Liquicolor Procalcitonin immunoturbidimetric assay, is precise, convenient, and cost effective, as it is in a liquid-stable format that can remain stable on-board a clinical chemistry analyzer for up to four weeks and requires a minimal sample of just 20 microliters. Procalcitonin levels become elevated during systemic bacterial infection and sepsis and are an early and specific indicator of sepsis. The CE-marked Liquid Procalcitonin assay can be used on most automatic chemistry analyzers to quickly assess initial severity of sepsis.

Related Links:

EKF Diagnostics




Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Automatic Western Blot Analyzer
Tenfly Phoenix Blot Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.